Mary Dooley
Vermogen: 8 666 $ op 31-05-2026
Vermogen: 8 666 $ op 31-05-2026
Mary Beth Dooley is currently Chief Executive & Financial Officer at Synlogic, Inc., a position starting in 2025.
Formerly, Ms. Dooley was Senior Manager-Financial Planning Analysis at Idera Pharmaceuticals, Inc. from 2014 to 2018 and Assistant Vice President at Boston Private Bank & Trust Co. from 2005 to 2011.
Education includes undergraduate studies at Bates College and graduate studies including an MBA at Northeastern University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SYNLOGIC INC 0,11% | 31-03-2026 | 12.744 ( 0,11% ) | 8 666 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNLOGIC, INC. | Algemeen Directeur | 01-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | 01-05-2018 |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Corporate Officer/Principal | 01-05-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Finance |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau